ARCHIVES

In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care

This article is from The Cancer Letter archive.

Vol. 01 No. 43 | October 24, 1975

Download PDF Visit The Full Archive

Related Articles

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989

Most of NCI’s Increase For Breast Cancer to Fund Grants: Broder

May 21, 1993

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

March 11, 2005

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006